Too bad this is from previous in-vivo (test tube) work and not from UTI patients like they said they would enrol in this trial. What happened?
Instead of having completed a phase 1/2 and moving to a phase 3 this year as they had planned, they completed another phase 1 and hope to start a phase 2 this year.
Too bad this is from previous in-vivo (test tube) work and not...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.020(6.90%) |
Mkt cap ! $89.39M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 32.8¢ | 29.0¢ | $78.39K | 251.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 916 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 114230 | 1 |
View Market Depth
| Last trade - 15.59pm 25/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |